Oct 15, 2026 07:01AM
Oct 15, 2026 07:00AM
Sep 29, 2026 07:30AM
Sep 29, 2026 07:30AM
Aug 13, 2026 07:15AM
Jul 30, 2026 08:05AM
Jul 15, 2026 07:30AM Cellectar publishes Phase 1 data on iopofosine I 131 in myeloma patients
Jul 15, 2026 07:30AM
Jun 1, 2026 08:05AM
Jun 1, 2026 08:05AM
May 14, 2026 07:15AM
May 11, 2026 08:05AM
May 5, 2026 07:10AM
May 5, 2026 07:10AM Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
May 5, 2026 07:03AM
May 5, 2026 07:00AM
Apr 21, 2026 10:01AM
Apr 21, 2026 10:00AM
Apr 14, 2026 08:35AM
Apr 14, 2026 08:35AM
Mar 4, 2026 07:15AM Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
Feb 25, 2026 08:05AM
Feb 17, 2026 08:05AM
Jan 9, 2026 08:05AM
Nov 13, 2025 07:20AM
Nov 6, 2025 08:05AM
Oct 27, 2025 08:33AM
Oct 27, 2025 08:30AM Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
Oct 14, 2025 08:30AM
Oct 14, 2025 08:30AM
Oct 7, 2025 08:31AM
Oct 7, 2025 08:30AM
Oct 6, 2025 07:01AM
Oct 6, 2025 07:00AM
Sep 30, 2025 08:30AM Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
Sep 24, 2025 08:30AM
Sep 9, 2025 08:05AM
Sep 5, 2025 08:45AM
Sep 3, 2025 08:05AM
Aug 27, 2025 08:05AM
Aug 14, 2025 07:19AM
Aug 7, 2025 08:05AM Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 14, 2025
Jun 26, 2025 08:05AM
Jun 26, 2025 08:05AM
Jun 24, 2025 08:30AM
Jun 18, 2025 04:30PM
Jun 18, 2025 04:30PM
Jun 11, 2025 08:05AM
Jun 11, 2025 08:05AM Cellectar Biosciences Provides Update on CLOVER-2 Phase 1 Clinical Trial of Iopofosine I 131 in Pediatric Patients with Relapsed/Refractory High-Grade Glioma
Jun 5, 2025 09:00AM

335,242 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All